🇺🇸 FDA
Patent

US 12370256

Activation of resident memory T cells for the treatment of cancer

granted A61KA61K2039/505A61K2039/5252

Quick answer

US patent 12370256 (Activation of resident memory T cells for the treatment of cancer) held by Regents of the University of Minnesota expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Jul 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/505, A61K2039/5252, A61K2039/54, A61K2039/545